Concepedia
Statistics
Publications
7
Citations
299
H-Index
Active since
2004
Affiliations
Tongji Hospital(Current)
Huazhong University of Science and Technology
Dong Xi is an author at Tongji Hospital specializing in liver disease, medicine, and immunology.
Publications per year
2004–2021
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase
Ping Wei, Keqiang Fan, Hao Chen et al. · Biochemical and Biophysical Research Communications · 2005 · 106 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients
Yaguang Zhang, Xiaojing Wang, Xuezhen Li et al. · Cellular and Molecular Immunology · 2020 · 59 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +14
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China
Ming Wang, Weiming Yan, Weipeng Qi et al. · Hepatology International · 2020 · 42 citations · Full text
Medicine, Infectious Diseases, Internal Medicine +15
Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma
Ying Sun, Dong Xi, Wen Ding et al. · Hepatology International · 2014 · 32 citations · Full text
Medicine, Cell Biology, Immunology +17
Ursodesoxycholic acid alleviates liver fibrosis via proregeneration by activation of the ID1‐WNT2/HGF signaling pathway
Dong Xi, Yun Luo, Shan Lu et al. · Clinical and Translational Medicine · 2021 · 27 citations · Full text
Medicine, Molecular Biology, Pathobiology +17
1–5 of 7